Arlington Partners’s Alkermes ALKS Stock Holding History

Arlington Partners’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-7,000	Closed	-$297K	–	212
2018 Q3	$297K	Buy	+7,000	New	+$304K	0.21%	61

Other funds holding ALKS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Arlington Partners's ALKS Position: Q4 2018 in Review

Arlington Partners sold out of Alkermes (ALKS) in Q4 2018, closing a stake of 7,000 shares — an estimated $297K sold.

Arlington Partners first reported a position in ALKS in Q3 2018 and held it in 1 quarter. The position peaked at $297K in Q3 2018. 237 funds tracked by Wall St. Rank hold ALKS as of Q4 2018.

Arlington Partners reported no remaining Alkermes position as of Q4 2018 after selling out during the quarter.
Arlington Partners sold 7,000 Alkermes shares in Q4 2018, an estimated $297K.
Arlington Partners first reported a position in Alkermes in Q3 2018 and held it in 1 quarter.
Arlington Partners's Alkermes position peaked at $297K in Q3 2018.
237 funds tracked by Wall St. Rank held Alkermes as of Q4 2018.

Based on Arlington Partners's 13F filing for Q4 2018, filed 10 Jan 2019.